Articles from:
2005 Business Development Articles
NEWS
- October 2005
- In China, biotech startups are struggling to make a go of it. But new models for survival are emerging.
- October 2005
- Few things are misunderstood more by biotech startup management teams than the importance of creating working space conducive to innovation and productivity, and compatible with the company's vision. Aesthetics, form and function matter.
- September 2005
- Because of their scale and cost advantages, virtual biotechs are attracting growing interest again. In theory, any element in the innovation chain of a biotech or medical device firm can be outsourced. In practice, the virtual model represents challenges to both investors and management.
NEWS
- July 2005
- Some of the world's top scientists and business school graduates are women, so why are so few of them holding senior-level management positions in biotech?
NEWS
- July 2005
- New revelations at the US National Institutes of Health dims any hope of a compromise with scientists and industry.
- April 2005
- Turning competitive intelligence into knowledge is a multi-layered process. In this second of two articles on competitive intelligence, we outline the steps involved and point out some of the potential pitfalls.
NEWS
- April 2005
- European governments see manufacturing as a vital next step toward developing a robust local biotech industry—and an essential fortification to protect their investments in the field.
NEWS
- March 2005
- A new program to train workers in the skills required to work in the biotech sector offer a career opportunity to some but are still too few and far between.
- March 2005
- Competitive intelligence (CI) gathering is essential to developing a biotech firm's business strategy, but few startups have sufficient support systems in place to do CI effectively. This article, the first of two on the topic, addresses why it is important and how to do it.
NEWS
- March 2005
- Talent rather than money may now be the rate-limiting factor in the emergence of new biotech companies.
- February 2005
- As the complexity and expense of clinical development grows, there is considerable pressure on companies to maximize the potential of a clinical study.
Main navigation
NPG Journals
by Subject Area
Chemistry
Clinical Practice & Research
Earth & Environment
Life sciences
Physical sciences
Top
